APA

Chresta C. M., Davies B. R., Hickson I., Harding T., Cosulich S., Critchlow S. E., Vincent J. P., Ellston R., Jones D., Sini P., James D., Howard Z., Dudley P., Hughes G., Smith L., Maguire S., Hummersone M., Malagu K., Menear K., Jenkins R., Jacobsen M., Smith G. C. M., Guichard S. & Pass M. (20100126). AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. : Cancer research.

Chicago

Chresta Christine M, Davies Barry R, Hickson Ian, Harding Tom, Cosulich Sabina, Critchlow Susan E, Vincent John P, Ellston Rebecca, Jones Darren, Sini Patrizia, James Dominic, Howard Zoe, Dudley Phillippa, Hughes Gareth, Smith Lisa, Maguire Sharon, Hummersone Marc, Malagu Karine, Menear Keith, Jenkins Richard, Jacobsen Matt, Smith Graeme C M, Guichard Sylvie and Pass Martin. 20100126. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. : Cancer research.

Harvard

Chresta C. M., Davies B. R., Hickson I., Harding T., Cosulich S., Critchlow S. E., Vincent J. P., Ellston R., Jones D., Sini P., James D., Howard Z., Dudley P., Hughes G., Smith L., Maguire S., Hummersone M., Malagu K., Menear K., Jenkins R., Jacobsen M., Smith G. C. M., Guichard S. and Pass M. (20100126). AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. : Cancer research.

MLA

Chresta Christine M, Davies Barry R, Hickson Ian, Harding Tom, Cosulich Sabina, Critchlow Susan E, Vincent John P, Ellston Rebecca, Jones Darren, Sini Patrizia, James Dominic, Howard Zoe, Dudley Phillippa, Hughes Gareth, Smith Lisa, Maguire Sharon, Hummersone Marc, Malagu Karine, Menear Keith, Jenkins Richard, Jacobsen Matt, Smith Graeme C M, Guichard Sylvie and Pass Martin. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. : Cancer research. 20100126.